ATOS - Atossa Genetics Inc.
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Annual
| Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
| Total Revenue | - | - | 1.758 | 40.138 |
| Cost of Revenue | - | - | 132.411 | - |
| Gross Profit | - | - | -130.653 | 40.138 |
| Operating Expenses | ||||
| Research Development | 2,328.087 | 770.427 | 2,359.593 | 1,110.329 |
| Selling General and Administrative | 4,859.369 | 6,479.193 | 10,268.372 | 8,748.211 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 7,187.456 | 7,249.62 | 12,760.376 | 9,858.54 |
| Operating Income or Loss | -7,187.456 | -7,249.62 | -12,758.618 | -9,818.402 |
| Income from Continuing Operations | ||||
| Total Other Income/Expenses Net | -935.125 | 880.735 | 0.431 | -2,352.366 |
| Earnings Before Interest and Taxes | -7,187.456 | -7,249.62 | -12,758.618 | -9,818.402 |
| Interest Expense | - | - | - | - |
| Income Before Tax | -8,122.581 | -6,368.885 | -12,758.187 | -12,170.768 |
| Income Tax Expense | - | - | - | - |
| Minority Interest | - | - | - | - |
| Net Income From Continuing Ops | -8,122.581 | -6,368.885 | -12,758.187 | -12,170.768 |
| Non-recurring Events | ||||
| Discontinued Operations | - | - | -3,002.136 | -2,487.158 |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income | ||||
| Net Income | -8,122.581 | -6,368.885 | -15,760.323 | -14,657.926 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | -10,690.713 | -6,368.885 | -15,760.323 | -14,657.926 |
